相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Total and phosphorylated tau protein as biological markers of Alzheimer's disease
Harald Hampel et al.
EXPERIMENTAL GERONTOLOGY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid Biomarkers and Rate of Cognitive Decline in Very Mild Dementia of the Alzheimer Type
Barbara J. Snider et al.
ARCHIVES OF NEUROLOGY (2009)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
Timo Grimmer et al.
BIOLOGICAL PSYCHIATRY (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
CSF biomarkers in relationship to cognitive profiles in Alzheimer disease
A. E. van der Vlies et al.
NEUROLOGY (2009)
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
N. A. Verwey et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
Biochemical markers in persons with preclinical familial Alzheimer disease
J. M. Ringman et al.
NEUROLOGY (2008)
A novel mutation in the PSEN1 gene (L286P) associated with familial early-onset dementia of Alzheimer type and lobar haematomas
R. Sanchez-Valle et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Cerebrospinal fluid β-amyloid 1-42 concentration may predict cognitive decline in older women
Deborah R. Gustafson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly
Erik Stomrud et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Neuropathology of older persons without cognitive impairment from two community-based studies
D. A. Bennett et al.
NEUROLOGY (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Familial Alzheimer disease:: Decreases in CSF Aβ42 levels precede cognitive decline
M Moonis et al.
NEUROLOGY (2005)
Longitudinal observation on CSF Aβ42 levels in young to middle-aged amyloid precursor protein/presenilin-1 doubly transgenic mice
L Liu et al.
NEUROBIOLOGY OF DISEASE (2004)
Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairment
O Almkvist et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Clinical and biomarker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild cognitive impairment stage of Alzheimer's disease
S Matsushita et al.
BIOLOGICAL PSYCHIATRY (2002)
Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
J Götz et al.
SCIENCE (2001)
分享论文
